Connection

Donald Castell to Drug Administration Schedule

Back to Details
This is a "connection" page, showing publications Donald Castell has written about Drug Administration Schedule.
Donald Castell
Connection Strength
0.609
Drug Administration Schedule
  1. Review of immediate-release omeprazole for the treatment of gastric acid-related disorders. Expert Opin Pharmacother. 2005 Nov; 6(14):2501-10.
    View in: PubMed
    Score: 0.058
  2. Comparison of the effects of immediate-release omeprazole powder for oral suspension and pantoprazole delayed-release tablets on nocturnal acid breakthrough in patients with symptomatic gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2005 Jun 15; 21(12):1467-74.
    View in: PubMed
    Score: 0.057
  3. Histamine-2 receptor antagonists at night improve gastroesophageal reflux disease symptoms for patients on proton pump inhibitor therapy. Dis Esophagus. 2005; 18(6):370-3.
    View in: PubMed
    Score: 0.055
  4. Nocturnal acid breakthrough: pH, drugs and bugs. Eur J Gastroenterol Hepatol. 2004 May; 16(5):441-3.
    View in: PubMed
    Score: 0.053
  5. Bedtime H2 blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitors. Aliment Pharmacol Ther. 2001 Sep; 15(9):1351-6.
    View in: PubMed
    Score: 0.044
  6. Gastric acidity and acid breakthrough with twice-daily omeprazole or lansoprazole. Aliment Pharmacol Ther. 2000 Jun; 14(6):709-14.
    View in: PubMed
    Score: 0.040
  7. A practical approach to heartburn. Hosp Pract (1995). 1999 Nov 15; 34(12):89-94, 97-8.
    View in: PubMed
    Score: 0.039
  8. Cisapride 20 mg b.d. for preventing symptoms of GERD induced by a provocative meal. The CIS-USA-89 Study Group. Aliment Pharmacol Ther. 1999 Jun; 13(6):787-94.
    View in: PubMed
    Score: 0.037
  9. Different effects of an oral anticholinergic drug on gastroesophageal reflux in upright and supine position in normal, ambulant subjects: a pilot study. Am J Gastroenterol. 1999 Apr; 94(4):925-30.
    View in: PubMed
    Score: 0.037
  10. Management options for patients with GERD and persistent symptoms on proton pump inhibitors: recommendations from an expert panel. Am J Gastroenterol. 2018 07; 113(7):980-986.
    View in: PubMed
    Score: 0.035
  11. Acid control and regression of Barrett's esophagus: is the glass half full or half empty? Am J Gastroenterol. 1997 Dec; 92(12):2329-30.
    View in: PubMed
    Score: 0.034
  12. Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: testing while on therapy identifies the need for more aggressive anti-reflux therapy. Am J Gastroenterol. 1996 Oct; 91(10):2110-3.
    View in: PubMed
    Score: 0.031
  13. Persistent acid secretion during omeprazole therapy: a study of gastric acid profiles in patients demonstrating failure of omeprazole therapy. Am J Gastroenterol. 1996 Aug; 91(8):1527-31.
    View in: PubMed
    Score: 0.031
  14. Optimal dosing of omeprazole 40 mg daily: effects on gastric and esophageal pH and serum gastrin in healthy controls. Am J Gastroenterol. 1996 Aug; 91(8):1532-8.
    View in: PubMed
    Score: 0.031
  15. Omeprazole for the treatment of posterior laryngitis. Am J Med. 1995 Dec; 99(6):694-5.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.